---
title: "AGOPYAN NADIA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4073a826-c28f-5e13-a2ca-3d6fecb0740f
json: https://whiteintel.dev/api/public/dossier/4073a826-c28f-5e13-a2ca-3d6fecb0740f
identifier: sec:0001784758
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AGOPYAN NADIA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001784758`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4073a826-c28f-5e13-a2ca-3d6fecb0740f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4073a826-c28f-5e13-a2ca-3d6fecb0740f  

## Ownership & control

### Holdings / subsidiaries

- **Marker Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1cdd4569-686b-5a8f-a51c-7a80d34ee9f8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AGOPYAN NADIA**. Human view: https://whiteintel.dev/entity/4073a826-c28f-5e13-a2ca-3d6fecb0740f · Structured JSON: https://whiteintel.dev/api/public/dossier/4073a826-c28f-5e13-a2ca-3d6fecb0740f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._